| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advantageous Solubility-Permeability Interplay When Using Amorphous Solid Dispersion (ASD) Formulation for the BCS Class IV P-gp Substrate Rifaximin: Simultaneous Increase of Both the Solubility and the Permeability
|
Beig, Avital
|
|
2017
|
19 |
3 |
p. 806-813
|
artikel
|
| 2 |
A Heparin Purification Process Removes Spiked Transmissible Spongiform Encephalopathy Agent
|
Bett, Cyrus
|
|
2017
|
19 |
3 |
p. 765-771
|
artikel
|
| 3 |
A LC-MS All-in-One Workflow for Site-Specific Location, Identification and Quantification of N-/O- Glycosylation in Human Chorionic Gonadotropin Drug Products
|
Zhu, Hongbin
|
|
2017
|
19 |
3 |
p. 846-855
|
artikel
|
| 4 |
Application of Pharmacokinetics and Pharmacodynamics in Product Life Cycle Management. A Case Study with a Carbidopa-Levodopa Extended-Release Formulation
|
Modi, Nishit B.
|
|
2017
|
19 |
3 |
p. 607-618
|
artikel
|
| 5 |
A Proposal to Redefine Clinical Immunogenicity Assessment
|
Mytych, Daniel T.
|
|
2017
|
19 |
3 |
p. 599-602
|
artikel
|
| 6 |
Aptamer-Conjugated Chitosan-Anchored Liposomal Complexes for Targeted Delivery of Erlotinib to EGFR-Mutated Lung Cancer Cells
|
Li, Fengqiao
|
|
2017
|
19 |
3 |
p. 814-826
|
artikel
|
| 7 |
Assessment of Correlation Between Early and Late Efficacy Endpoints to Identify Potential Surrogacy Relationships in Non-Hodgkin Lymphoma: a Literature-Based Meta-analysis of 108 Phase II and Phase III Studies
|
Zhu, Rui
|
|
2017
|
19 |
3 |
p. 669-681
|
artikel
|
| 8 |
Challenges and Future Prospects for the Delivery of Biologics: Oral Mucosal, Pulmonary, and Transdermal Routes
|
Morales, Javier O.
|
|
2017
|
19 |
3 |
p. 652-668
|
artikel
|
| 9 |
Characterising Drug Release from Immediate-Release Formulations of a Poorly Soluble Compound, Basmisanil, Through Absorption Modelling and Dissolution Testing
|
Stillhart, Cordula
|
|
2017
|
19 |
3 |
p. 827-836
|
artikel
|
| 10 |
Colloidal Gels with Extracellular Matrix Particles and Growth Factors for Bone Regeneration in Critical Size Rat Calvarial Defects
|
Townsend, Jakob M.
|
|
2017
|
19 |
3 |
p. 703-711
|
artikel
|
| 11 |
Current Trends in Ligand Binding Real-Time Measurement Technologies
|
Fraser, Stephanie
|
|
2017
|
19 |
3 |
p. 682-691
|
artikel
|
| 12 |
Development Considerations for Nanocrystal Drug Products
|
Chen, Mei-Ling
|
|
2017
|
19 |
3 |
p. 642-651
|
artikel
|
| 13 |
Erratum to: Reliable Rate Measurements for Active and Passive Hepatic Uptake Using Plated Human Hepatocytes
|
Bi, Yi-an
|
|
2017
|
19 |
3 |
p. 882
|
artikel
|
| 14 |
Erratum to: Systematic Verification of Bioanalytical Similarity Between a Biosimilar and a Reference Biotherapeutic: Committee Recommendations for the Development and Validation of a Single Ligand-Binding Assay to Support Pharmacokinetic Assessments
|
Marini, Joseph C.
|
|
2017
|
19 |
3 |
p. 883
|
artikel
|
| 15 |
Evaluation of the Potency, Neutralizing Antibody Response, and Stability of a Recombinant Fusion Protein Vaccine for Streptococcus pyogenes
|
Burlet, E.
|
|
2017
|
19 |
3 |
p. 875-881
|
artikel
|
| 16 |
Evaluation of the Potency, Neutralizing Antibody Response, and Stability of a Recombinant Fusion Protein Vaccine for Streptococcus pyogenes
|
Burlet, E.
|
|
|
19 |
3 |
p. 875-881
|
artikel
|
| 17 |
Exploring Canine-Human Differences in Product Performance. Part II: Use of Modeling and Simulation to Explore the Impact of Formulation on Ciprofloxacin In Vivo Absorption and Dissolution in Dogs
|
Martinez, M. N.
|
|
2017
|
19 |
3 |
p. 712-726
|
artikel
|
| 18 |
Global Harmonization of Comparator Products for Bioequivalence Studies
|
Gwaza, Luther
|
|
2017
|
19 |
3 |
p. 603-606
|
artikel
|
| 19 |
Identifying Metabolites of Meclonazepam by High-Resolution Mass Spectrometry Using Human Liver Microsomes, Hepatocytes, a Mouse Model, and Authentic Urine Samples
|
Vikingsson, Svante
|
|
2017
|
19 |
3 |
p. 736-742
|
artikel
|
| 20 |
Inclusion of Digestible Surfactants in Solid SMEDDS Formulation Removes Lag Time and Influences the Formation of Structured Particles During Digestion
|
Vithani, Kapilkumar
|
|
2017
|
19 |
3 |
p. 754-764
|
artikel
|
| 21 |
Liposomal Drug Product Development and Quality: Current US Experience and Perspective
|
Kapoor, Mamta
|
|
2017
|
19 |
3 |
p. 632-641
|
artikel
|
| 22 |
Modeling a Composite Score in Parkinson’s Disease Using Item Response Theory
|
Gottipati, Gopichand
|
|
2017
|
19 |
3 |
p. 837-845
|
artikel
|
| 23 |
Pharmacokinetics of the Inhaled Selective Glucocorticoid Receptor Modulator AZD5423 Following Inhalation Using Different Devices
|
Melin, Johanna
|
|
2017
|
19 |
3 |
p. 865-874
|
artikel
|
| 24 |
Pharmacokinetic Steady-States Highlight Interesting Target-Mediated Disposition Properties
|
Gabrielsson, Johan
|
|
2017
|
19 |
3 |
p. 772-786
|
artikel
|
| 25 |
Phloretin Prevents High-Fat Diet-Induced Obesity and Improves Metabolic Homeostasis
|
Alsanea, Sary
|
|
2017
|
19 |
3 |
p. 797-805
|
artikel
|
| 26 |
Population Pharmacokinetic-Pharmacodynamic Model of Oral Fludrocortisone and Intravenous Hydrocortisone in Healthy Volunteers
|
Hamitouche, Noureddine
|
|
2017
|
19 |
3 |
p. 727-735
|
artikel
|
| 27 |
Radiomitigation and Tissue Repair Activity of Systemically Administered Therapeutic Peptide TP508 Is Enhanced by PEGylation
|
McVicar, Scott D.
|
|
2017
|
19 |
3 |
p. 743-753
|
artikel
|
| 28 |
Reliable Rate Measurements for Active and Passive Hepatic Uptake Using Plated Human Hepatocytes
|
Bi, Yi-an
|
|
2017
|
19 |
3 |
p. 787-796
|
artikel
|
| 29 |
Scientific and Regulatory Considerations for Generic Complex Drug Products Containing Nanomaterials
|
Zheng, Nan
|
|
2017
|
19 |
3 |
p. 619-631
|
artikel
|
| 30 |
Spray-Dried Thiolated Chitosan-Coated Sodium Alginate Multilayer Microparticles for Vaginal HIV Microbicide Delivery
|
Meng, Jianing
|
|
2017
|
19 |
3 |
p. 692-702
|
artikel
|
| 31 |
Structure-Promiscuity Relationship Puzzles—Extensively Assayed Analogs with Large Differences in Target Annotations
|
Hu, Ye
|
|
2017
|
19 |
3 |
p. 856-864
|
artikel
|
Tijdschrift beschrijving